Coatings containing multiple drugs
First Claim
Patent Images
1. A method of preparing a multi-drug eluting coronary stent comprising:
- a. providing a stent framework;
b. depositing on said stent framework a first layer comprising a first pharmaceutical agent in dry powder form without use of a solvent;
c. depositing a second layer in dry powder form without use of a solvent, the second layer comprising a second pharmaceutical agent;
d. depositing one or more polymer layers thereby forming a coating; and
thene. sintering said coating under conditions that do not substantially modify a morphology of said pharmaceutical agents, wherein said sintering comprises treating the coated stent framework with a compressed gas, compressed liquid, or super critical fluid that is a non-solvent for both the polymer and pharmaceutical agents;
wherein said first and second pharmaceutical agents are selected from two different classes of pharmaceutical agents and at least one of said first and second pharmaceutical agents comprises the morphology that is crystalline or semi-crystalline.
7 Assignments
0 Petitions
Accused Products
Abstract
A method for depositing a coating comprising a polymer and at least two pharmaceutical agents on a substrate, comprising the following steps: providing a stent framework; depositing on said stent framework a first layer comprising a first pharmaceutical agent; depositing a second layer comprising a second pharmaceutical agent; Wherein said first and second pharmaceutical agents are selected from two different classes of pharmaceutical agents.
-
Citations
38 Claims
-
1. A method of preparing a multi-drug eluting coronary stent comprising:
-
a. providing a stent framework; b. depositing on said stent framework a first layer comprising a first pharmaceutical agent in dry powder form without use of a solvent; c. depositing a second layer in dry powder form without use of a solvent, the second layer comprising a second pharmaceutical agent; d. depositing one or more polymer layers thereby forming a coating; and
thene. sintering said coating under conditions that do not substantially modify a morphology of said pharmaceutical agents, wherein said sintering comprises treating the coated stent framework with a compressed gas, compressed liquid, or super critical fluid that is a non-solvent for both the polymer and pharmaceutical agents; wherein said first and second pharmaceutical agents are selected from two different classes of pharmaceutical agents and at least one of said first and second pharmaceutical agents comprises the morphology that is crystalline or semi-crystalline. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21)
-
-
22. A multi-drug coronary stent comprising
a. a stent framework; -
b. a first layer comprising a first pharmaceutical agent; c. a second layer comprising a second pharmaceutical agent; and d. one or more polymer layers thereby forming a coating; wherein said coating is sintered under conditions that do not substantially modify the morphology of said pharmaceutical agents, wherein said sintering comprises treating the coated stent framework with a compressed gas, compressed liquid, or super critical fluid that is a non-solvent for both the polymer and pharmaceutical agents; wherein said first and second pharmaceutical agents are selected from two different classes of pharmaceutical agents and at least one of said first and second pharmaceutical agents are crystalline or semi-crystalline; and
wherein the stent has no residual solvent. - View Dependent Claims (23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38)
-
Specification